Collegium Pharmaceutical, Inc. COLL Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s other intangible assets—net?
- Collegium Pharmaceutical, Inc. (COLL) reported other intangible assets—net of $614.04M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s other intangible assets—net changed year-over-year?
- Collegium Pharmaceutical, Inc.'s other intangible assets—net decreased by 26.5% year-over-year, from $835.93M to $614.04M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s other intangible assets—net?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s other intangible assets—net has grown at a 25.6% compound annual growth rate (CAGR), from $268.72M to $669.51M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.